We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03645395
Brief Title: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Lenalidomide for the Treatment of Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (MT-3724_NHL_003)

First Submitted : July 19, 2018
First Submitted that Met QC Criteria : August 22, 2018
First Posted : August 24, 2018

Results First Submitted : June 1, 2022
Results First Posted with QC Comments : June 28, 2022
Results First Submitted that Met QC Criteria : July 18, 2022
Results First Posted : August 16, 2022

Last Update Submitted that Met QC Criteria : July 18, 2022
Last Update Posted : August 16, 2022